Hot Topics medtech coverage includes analysis, news, and other vital resources. Explore topics like Brexit’s influence on medical device registration, medtech reimbursement developments, EU MDR implementation, and much more.
100+ Total results for product and free and sample content found
The start date for voluntary registration in the Eudamed 3 database is fast approaching. It is open to all medtech manufacturers with CE marked medical devices from 1 December
US senatorial friends of the device industry running competitive races in 2020 are being aided by medtech PAC dollars this fall
The Cumberlege Review of patient safety delivered a damning verdict on the UK’s health system. Its recommendations must be acted on, says a consensus of stakeholders.
In Vivo brings you another exclusive look into the future of biopharma, medtech and healthtech with our new article pack that features interviews with rising leaders and established executives, all sharing their insight. Download your free pack for a view of how today’s rising leaders are shaping the life sciences industries of tomorrow.
Find out who is coming through the ranks of biopharma, medtech and healthtech organizations with In Vivo’s infographic, “30 Rising Leaders of 2020”. Your free infographic provides a snapshot view of the entrepreneurs and innovators who are moving their industries forward with creative thinking and new technologies.
Medtech Insight takes you deeper into the world of robotic surgery with your free article pack, containing insights and analysis for upcoming changes to the area. Keep up with the latest developments as medtech giants enter the space for the first time.
Robotic surgery is revolutionizing healthcare. With a number of medtech giants planning on entering the robotics market in 2020, the area is poised for a shakeup. Gain deeper insights into what’s ahead for robotic surgery with your free analysis from Medtech Insight.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
AlloVir/Baylor, Soligenix/Hawaii and CEL-SCI/Georgia ink coronavirus collaborations, but deal-making continues in other areas as well, including Asklepios/UNC teaming on a gene therapy for Angelman syndrome and DeMelle licensing a targeted pancreatic cancer drug from Moffitt, among others.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: